טוען...
Prevalence of high-risk cardiovascular patients with therapy-resistant hypercholesterolemia
Hypercholesterolemia is a causal risk factor for cardiovascular diseases, which is recommended to be treated at least in high-risk patients. Yet, currently there is a lack of epidemiological data on the number of high-risk patients in Germany who do not respond adequately to high-dose statin monothe...
שמור ב:
| הוצא לאור ב: | Cardiovasc Endocrinol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Wolters Kluwer Health
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5427976/ https://ncbi.nlm.nih.gov/pubmed/28540139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/XCE.0000000000000098 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|